EXHIBIT A --------- AGREEMENT OF REPORTING PERSONS Each of the undersigned hereby agrees that Amendment No. 2 to the Schedule 13G filed on the date hereof with respect to the shares of Common Stock of InterNAP Network Services Corporation has been...Schedule 13g Amendment • August 1st, 2001 • Oak Management Corp • Textile mill products
Each of the undersigned hereby agrees that Amendment No. 2 to the Schedule 13G filed on the date hereof with respect to the shares of Common Stock of InterNAP Network Services Corporation has been filed on behalf of the undersigned.
JOINT FILING AGREEMENTSchedule 13g Amendment • February 12th, 2007 • Discovery Group I, LLC • Radio broadcasting stations
The undersigned hereby agree to the joint filing of the Amendment No. 2 to the Schedule 13G to which this Agreement is attached.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Catalyst Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value per share, of Vanda Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Ordinary Shares, par value NIS 0.25, of ReWalk Robotics Ltd. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 14th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Enanta Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
Agreement of Reporting PersonsSchedule 13g Amendment • February 10th, 2004 • Oak Management Corp • Services-computer programming, data processing, etc.
Each of the undersigned hereby agrees that Amendment No. 6 to the Schedule 13G filed on the date hereof with respect to the shares of Common Stock of InterNAP Network Services Corporation has been filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Surgical & medical instruments & apparatus
The undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of ReShape Lifesciences Inc. shall be filed on behalf of the undersigned.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Services-misc health & allied services, nec
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01, of Baudax Bio, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Orthopedic, prosthetic & surgical appliances & supplies
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.00001 per share, of Conformis, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Citius Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • In vitro & in vivo diagnostic substances
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Lantheus Holdings, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Enanta Pharmaceuticals Inc. shall be filed on behalf of the undersigned.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.01 per share, of Bellicum Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Assembly Biosciences, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Amendment No. 1 to Schedule 13G dated February 14, 2022 relating to the Common Shares, of Intellipharmaceutics International Inc. shall be filed on behalf of the undersigned.
Exhibit A AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Dental equipment & supplies
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of BIOLASE, Inc. shall be filed on behalf of the undersigned.
Agreement of Reporting PersonsSchedule 13g Amendment • February 10th, 2004 • Oak Management Corp • Services-business services, nec
Each of the undersigned hereby agrees that Amendment No. 4 to Schedule 13G filed on the date hereof with respect to the shares of Common Stock of aQuantive, Inc. has been filed on behalf of the undersigned.
